This summer, APDA participated in the 6th World Parkinson Congress (WPC)...see more in Barcelona, Spain. We are thankful for the incredible connections we made, the inspiring conversations we had, the compelling presentations we attended, and so much more! WPC is geared toward both people with PD and medical […]

Read More

The Central New Jersey Chamber of Commerce hosted a nine-hole golf tournament in...see more May to benefit APDA. Organized by the dedicated members of the Central New Jersey Chamber of Commerce, golfers enjoyed some friendly competition on the course, followed by a celebratory luncheon. APDA representatives were invited to meet […]

Read More

Parkinson’s disease can make it difficult for partners to maintain a healthy relationship, especially...see more when it comes to intimacy. Symptoms of PD can affect the well-being of your relationship, and a couple may grow apart physically and emotionally because of it. Although sexual intimacy can be challenging for many people […]

Read More

Tools for daily success Join us for our brand-new three-part web series, Thriving Through Occupational...see more Therapy, where we explore the world of occupational therapy (OT) and the many ways it can benefit people living with PD. Hosted by trained OT experts, we share practical knowledge and provide tips and tricks to […]

Read More

Q: Can travel affect PD symptoms? A:  Yes, in several ways. First,...see more travel can be exhausting, especially when dealing with time changes — and that fatigue can make PD symptoms seem worse. In addition, timing of medication doses can be difficult to manage when you’re changing time zones […]

Read More

From understanding levodopa induced dyskinesias to exploring environmental risk factors of PD, APDA-funded...see more researchers launch cutting-edge studies With someone diagnosed with PD every six minutes, scientific research is critical as we push for better treatments and ultimately, a cure. Devoted to our search for answers, APDA recently awarded $1.975 […]

Read More

Clinical Research Study in Mild Cognitive Impairment associated with Parkinson’s Disease (PD-MCI) The PRECEDENT study...see more is evaluating an investigational treatment for cognitive deficits such as memory and attention in Parkinson’s. This phase 2 study is sponsored by Sage Therapeutics, Inc. and is recruiting people aged 50 to 75 years who are […]

Read More